Core Insights - The orthopedic surgical robot market in public hospitals in China continues to grow, with a total of 84 units awarded in 2025, involving 18 manufacturers. The leading company, Tianzhihang, secured 28 units, maintaining a significant lead over competitors [2][3][4]. Overall Landscape - Tianzhihang remains the dominant player in the orthopedic surgical robot market, winning 28 units in 2025, significantly higher than other manufacturers. The competition among other manufacturers is characterized by a "many parallel, vying for supremacy" pattern, with key competitors including Jianjia (10 units), Rosenbot (7 units), Tadao (6 units), and Stryker (5 units [3][4][5]. Bid Quantity and Amount - In 2025, 76 projects disclosed procurement amounts, totaling approximately 643 million yuan. Tianzhihang led both in quantity and total bid amount, with 28 units corresponding to about 221 million yuan. Other notable manufacturers include Jianjia and Rosenbot, with total amounts of approximately 63 million yuan and 62 million yuan, respectively [7][8]. Hospital Dimension - Public hospital bidding reflects only a portion of the orthopedic robot market. The market also includes private hospitals, specialized medical institutions, and overseas markets. The procurement data serves as a lens to observe public hospital purchasing logic rather than a complete market representation [11][12]. - The procurement landscape shows a clear multi-tier structure, with hospitals ranging from national orthopedic centers to local and specialized hospitals. This indicates that orthopedic surgical robots are being integrated into various hospital capabilities based on their specific needs [12][14]. - The predominant configuration method is "single unit introduction," reflecting a rational validation approach rather than simple budget constraints. Hospitals prefer to validate the technology and team capabilities before expanding their configurations [13][15]. - Some leading hospitals have begun to adopt multiple brands, indicating a trend towards diversified clinical applications. For instance, Beijing University Third Hospital has integrated multiple robotic systems from different manufacturers within the same year [14][15].